Crossmark

[Translated article] Cost-utility of sacubitril/valsartan in heart failure with reduced ejection fraction in Spain

Crossref DOI link: https://doi.org/10.1016/j.farma.2025.08.004

Published Print: 2025-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García-Quintana, Antonio

Alonso Ramos, Héctor

Parrondo, Javier
Funding

Funding for this research was provided by:

Novartis Farmacéutica
License Information

Text and Data Mining valid from 2025-11-01

Text and Data Mining valid from 2025-11-01

Version of Record valid from 2025-08-06
More Information

This article is maintained by: Elsevier

Article Title: [Translated article] Cost-utility of sacubitril/valsartan in heart failure with reduced ejection fraction in Spain

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2025.08.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.farma.2025.04.004

Content Type: article

Copyright: © 2025 The Author(s). Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Farmacia Hospitalaria (S.E.F.H).